Displaying 2881 - 2900 of 4402
FTC Amicus Brief: Improper Use of Restricted Drug Distribution Programs May Impede Generic Competition
FTC Staff Makes Recommendations to Texas Public Utility Commission on Programs to Improve Reliability of Electricity Markets
FTC Approves Final Order Settling Charges That Non-Compete Agreement Harmed Competition in the Market for Bulk Bleach Used to Disinfect Water
FTC and DOJ Extend Public Comment Period for PAE Workshop Through April 5, 2013
Oltrin Solutions, LLC, a company; JCI Jones Chemicals, Inc.
The FTC required bleach producer and seller Oltrin Solutions, LLC to release its competitor, JCI Jones Chemicals, Inc. from an agreement not to sell bleach in North Carolina and South Carolina. This non-compete agreement was part of a 2010 transaction between the two firms that the FTC alleges violated antitrust laws. The FTC’s settlement with Oltrin and JCI will restore competition between these two producers and sellers of bulk bleach, which is primarily used to disinfect water. The FTC contends that the deal between the two firms eliminated substantial competition between Oltrin and JCI in the relevant geographic market; substantially increased the market concentration for bulk bleach sales in the relevant geographic market; and increased Oltrin’s ability to raise bulk bleach prices. The FTC order requires Oltrin to release JCI from the non-compete agreement, transfer a minimum volume of its bulk bleach contracts back to JCI, and provide a short-term backup supply agreement that will facilitate JCI’s re-entry into the bulk bleach market in North Carolina and South Carolina.
In Comments to the Colorado Public Utilities Commission, FTC Staff Expresses Concerns About Proposed Motor Vehicle Transportation Rules
Eight Puerto Rico Kidney Doctors Settle FTC Price-Fixing Charges
Statement of FTC Chairman Jon Leibowitz on the U.S. Supreme Court Ruling in Favor of the Commission in the Phoebe Putney/Palmyra Park Hospital Case
FTC Staff Advises Oklahoma Physician Hospital Organization That it Will Not Recommend Antitrust Challenge to Proposed Formation of Clinically Integrated Multi-provider Network
IDEXX Laboratories, Inc., In the Matter of
The largest U.S. supplier of diagnostic testing products used by small animal veterinarians, IDEXX Laboratories, Inc., agreed to drop its exclusive-dealing arrangements with a top distributor, resolving FTC charges that it was using the exclusive arrangements to stifle competition. IDEXX has agreed to a settlement order that prohibits concurrent exclusive distribution arrangements with the three national distributors of point-of-care (POC) diagnostic testing products. According to the FTC’s complaint, IDEXX has used its dominant market power to reduce competition by threatening to drop the distributors if they carried other companies’ products that compete with IDEXX products.
FTC Extends Deadline for Comments on its Review of Fred Meyer Guides
FTC Approves Final Order Settling Charges of Anticompetitive Conduct Against IDEXX Laboratories, Inc.
FTC Seeks Public Comments on Proposed Amendments to the Premerger Notification Rules Related to the Withdrawal of HSR Filings
FTC Extends Public Comment Period on Proposed Settlement Order Concerning Google and Motorola Mobility LLC. through February 22, 2013
FTC Staff Makes Recommendations to New York Public Service Commission on Competition and Consumer Protection Measures in Retail Electricity Markets
FTC Puts an End to Bleach Non-Compete Agreement That Whitewashed Competition in North Carolina, South Carolina, and Southern Virginia
FTC Study: In FY 2012, Branded Drug Firms Significantly Increased theUse of Potential Pay-for-Delay Settlements to Keep Generic Competitors off the Market
Displaying 2881 - 2900 of 4402